• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤抑制因子DAL-1/4.1B与蛋白质甲基化协同作用诱导MCF-7乳腺癌细胞凋亡。

The tumor suppressor DAL-1/4.1B and protein methylation cooperate in inducing apoptosis in MCF-7 breast cancer cells.

作者信息

Jiang Wei, Newsham Irene F

机构信息

Hermlein Brain Tumor Center, Department of Neurosurgery, Henry Ford Hospital, 2799 W, Grand Boulevard, Detroit, Michigan, USA.

出版信息

Mol Cancer. 2006 Jan 18;5:4. doi: 10.1186/1476-4598-5-4.

DOI:10.1186/1476-4598-5-4
PMID:16420693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1382251/
Abstract

BACKGROUND

DAL-1 (Differentially Expressed in Adenocarcinoma of the Lung)/4.1B is a member of the protein 4.1 superfamily that has been shown to suppress growth in lung, breast and brain tumor cells. In the case of the caspase-3 deficient MCF-7 breast cancer cells, this growth suppression has been shown to be partially mediated by the induction of apoptosis. However the exact mechanism of action of DAL-1/4.1B is unknown. Recently, protein arginine N-methyltransferase 3 (PRMT3) was identified as a DAL-1/4.1B interacting protein. Protein arginine methyltransferases (PRMTs) posttranslationally methylate the arginine residues of proteins, a modification which has been implicated in the regulation of multiple cellular processes including nuclear-cytoplasmic transport, signal transduction, and transcription.

RESULTS

To investigate the role of protein methylation in cell death induced by DAL-1/4.1B, DAL-1/4.1B-inducible MCF-7 cells were examined for apoptosis and caspase activation in the absence and presence of the protein methylation inhibitor adenosine dialdehyde (AdOX). Flow cytometry analysis revealed that apoptosis was primarily associated with the activation of caspase 8, and inhibition of this activation blocked the ability of DAL-1/4.1B to induce cell death.

CONCLUSION

These results suggest that protein methylation cooperates with DAL-1/4.1B-associated caspase 8-specific activation to induce apoptosis in breast cancer cells.

摘要

背景

DAL-1(在肺腺癌中差异表达)/4.1B是蛋白质4.1超家族的成员,已被证明可抑制肺、乳腺和脑肿瘤细胞的生长。在缺乏半胱天冬酶-3的MCF-7乳腺癌细胞中,这种生长抑制已被证明部分是由凋亡诱导介导的。然而,DAL-1/4.1B的确切作用机制尚不清楚。最近,蛋白质精氨酸N-甲基转移酶3(PRMT3)被鉴定为一种与DAL-1/4.1B相互作用的蛋白质。蛋白质精氨酸甲基转移酶(PRMTs)在翻译后将蛋白质的精氨酸残基甲基化,这种修饰与包括核质运输、信号转导和转录在内的多种细胞过程的调节有关。

结果

为了研究蛋白质甲基化在DAL-1/4.1B诱导的细胞死亡中的作用,在存在和不存在蛋白质甲基化抑制剂腺苷二醛(AdOX)的情况下,检测了DAL-1/4.1B诱导型MCF-7细胞的凋亡和半胱天冬酶激活情况。流式细胞术分析显示,凋亡主要与半胱天冬酶8的激活有关,抑制这种激活可阻断DAL-1/4.1B诱导细胞死亡的能力。

结论

这些结果表明,蛋白质甲基化与DAL-1/4.1B相关的半胱天冬酶8特异性激活协同作用,诱导乳腺癌细胞凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda9/1382251/62b86baa0d1d/1476-4598-5-4-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda9/1382251/0b69ed9e02d3/1476-4598-5-4-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda9/1382251/cb2cc999a88e/1476-4598-5-4-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda9/1382251/6229aacd37c5/1476-4598-5-4-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda9/1382251/62b86baa0d1d/1476-4598-5-4-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda9/1382251/0b69ed9e02d3/1476-4598-5-4-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda9/1382251/cb2cc999a88e/1476-4598-5-4-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda9/1382251/6229aacd37c5/1476-4598-5-4-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bda9/1382251/62b86baa0d1d/1476-4598-5-4-4.jpg

相似文献

1
The tumor suppressor DAL-1/4.1B and protein methylation cooperate in inducing apoptosis in MCF-7 breast cancer cells.肿瘤抑制因子DAL-1/4.1B与蛋白质甲基化协同作用诱导MCF-7乳腺癌细胞凋亡。
Mol Cancer. 2006 Jan 18;5:4. doi: 10.1186/1476-4598-5-4.
2
DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo.DAL-1/4.1B肿瘤抑制因子与蛋白质精氨酸N-甲基转移酶3(PRMT3)相互作用,并在体外和体内抑制其甲基化底物的能力。
Oncogene. 2004 Oct 14;23(47):7761-71. doi: 10.1038/sj.onc.1208057.
3
Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.在无突变情况下,DAL-1/4.1B(EPB41L3)肿瘤抑制基因位点的等位基因特异性杂合性缺失。
Genes Chromosomes Cancer. 2004 Jul;40(3):190-203. doi: 10.1002/gcc.20034.
4
The tumor suppressor DAL-1/4.1B modulates protein arginine N-methyltransferase 5 activity in a substrate-specific manner.肿瘤抑制因子DAL-1/4.1B以底物特异性方式调节蛋白质精氨酸N-甲基转移酶5的活性。
Biochem Biophys Res Commun. 2005 Apr 8;329(2):522-30. doi: 10.1016/j.bbrc.2005.01.153.
5
Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.茶黄素通过靶向 Fas/caspase-8 和 Akt/pBad 通路诱导 p53 突变型人乳腺癌细胞凋亡。
Carcinogenesis. 2010 Feb;31(2):259-68. doi: 10.1093/carcin/bgp240. Epub 2009 Dec 7.
6
Protein 4.1B/differentially expressed in adenocarcinoma of the lung-1 functions as a growth suppressor in meningioma cells by activating Rac1-dependent c-Jun-NH(2)-kinase signaling.蛋白质4.1B/在肺腺癌中差异表达-1通过激活Rac1依赖性c-Jun-NH(2)-激酶信号通路在脑膜瘤细胞中发挥生长抑制作用。
Cancer Res. 2006 May 15;66(10):5295-303. doi: 10.1158/0008-5472.CAN-05-1628.
7
Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.与肿瘤相关脂肪酸合酶依赖性乳腺癌细胞增殖和存活相关的新型信号分子:外源性膳食脂肪酸、p53-p21WAF1/CIP1、ERK1/2 MAPK、p27KIP1、BRCA1和NF-κB的作用
Int J Oncol. 2004 Mar;24(3):591-608.
8
Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cells.新型三萜类化合物25-羟基-3-氧代齐墩果-12-烯-28-酸诱导乳腺癌细胞生长停滞和凋亡。
Breast Cancer Res Treat. 2007 Jan;101(1):27-36. doi: 10.1007/s10549-006-9275-z.
9
Disruption of 14-3-3 binding does not impair Protein 4.1B growth suppression.破坏14-3-3结合不会损害蛋白4.1B的生长抑制作用。
Oncogene. 2004 Apr 29;23(20):3589-96. doi: 10.1038/sj.onc.1207445.
10
Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.DAL-1/4.1B的启动子甲基化预示着非小细胞肺癌的预后不良。
Clin Cancer Res. 2005 Apr 15;11(8):2954-61. doi: 10.1158/1078-0432.CCR-04-2206.

引用本文的文献

1
PRMT3 and CARM1: Emerging Epigenetic Targets in Cancer.PRMT3和CARM1:癌症中新兴的表观遗传靶点。
J Cell Mol Med. 2025 Feb;29(4):e70386. doi: 10.1111/jcmm.70386.
2
Clinical Proteomics Reveals Vulnerabilities in Noninvasive Breast Ductal Carcinoma and Drives Personalized Treatment Strategies.临床蛋白质组学揭示非侵袭性乳腺导管癌的脆弱性并推动个性化治疗策略
Cancer Res Commun. 2025 Jan 1;5(1):138-149. doi: 10.1158/2767-9764.CRC-24-0287.
3
Comprehensive single-cell aging atlas of healthy mammary tissues reveals shared epigenomic and transcriptomic signatures of aging and cancer.

本文引用的文献

1
Angiogenesis and apoptosis in glioma: two arenas for promising new therapies.胶质瘤中的血管生成与细胞凋亡:两个有望开发新疗法的领域。
J Cell Biochem. 2005 Sep 1;96(1):16-24. doi: 10.1002/jcb.20475.
2
Caspase-independent cell death.半胱天冬酶非依赖性细胞死亡
Nat Med. 2005 Jul;11(7):725-30. doi: 10.1038/nm1263.
3
Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to radiation therapy.半胱天冬酶-3的重组使MCF-7乳腺癌细胞对放射治疗敏感。
健康乳腺组织的综合单细胞衰老图谱揭示了衰老和癌症共有的表观基因组和转录组特征。
Nat Aging. 2025 Jan;5(1):122-143. doi: 10.1038/s43587-024-00751-8. Epub 2024 Nov 25.
4
Discovery of PRMT3 Degrader for the Treatment of Acute Leukemia.发现 PRMT3 降解剂可治疗急性白血病。
Adv Sci (Weinh). 2024 Oct;11(38):e2405963. doi: 10.1002/advs.202405963. Epub 2024 Aug 9.
5
Protein Arginine Methyltransferases in Pancreatic Ductal Adenocarcinoma: New Molecular Targets for Therapy.蛋白精氨酸甲基转移酶在胰腺导管腺癌中的作用:治疗的新分子靶点。
Int J Mol Sci. 2024 Apr 2;25(7):3958. doi: 10.3390/ijms25073958.
6
Expression and hypermethylation of JAM and EPB41L3 in cervical squamous cell carcinoma: Clinical significance and applications.JAM 和 EPB41L3 在宫颈鳞状细胞癌中的表达与甲基化:临床意义与应用。
Histol Histopathol. 2024 Aug;39(8):1043-1051. doi: 10.14670/HH-18-697. Epub 2023 Dec 26.
7
PRMT3-Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma.PRMT3 介导的 METTL14 精氨酸甲基化促进子宫内膜癌的恶性进展和治疗抵抗。
Adv Sci (Weinh). 2023 Dec;10(36):e2303812. doi: 10.1002/advs.202303812. Epub 2023 Nov 16.
8
Comprehensive single cell aging atlas of mammary tissues reveals shared epigenomic and transcriptomic signatures of aging and cancer.乳腺组织的综合单细胞衰老图谱揭示了衰老和癌症共有的表观基因组和转录组特征。
bioRxiv. 2023 Oct 23:2023.10.20.563147. doi: 10.1101/2023.10.20.563147.
9
Citrullination and the protein code: crosstalk between post-translational modifications in cancer.瓜氨酸化与蛋白质编码:癌症中翻译后修饰的串扰。
Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220243. doi: 10.1098/rstb.2022.0243. Epub 2023 Oct 2.
10
The Role of Cytoskeleton Protein 4.1 in Immunotherapy.细胞骨架蛋白 4.1 在免疫疗法中的作用。
Int J Mol Sci. 2023 Feb 14;24(4):3777. doi: 10.3390/ijms24043777.
Int J Oncol. 2005 Jun;26(6):1675-80.
4
The tumor suppressor DAL-1/4.1B modulates protein arginine N-methyltransferase 5 activity in a substrate-specific manner.肿瘤抑制因子DAL-1/4.1B以底物特异性方式调节蛋白质精氨酸N-甲基转移酶5的活性。
Biochem Biophys Res Commun. 2005 Apr 8;329(2):522-30. doi: 10.1016/j.bbrc.2005.01.153.
5
Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell.p53和半胱天冬酶3活性对乳腺肿瘤细胞中氨甲蝶呤诱导的细胞死亡和衰老的影响。
Biochem Pharmacol. 2004 Nov 1;68(9):1699-708. doi: 10.1016/j.bcp.2004.06.033.
6
DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo.DAL-1/4.1B肿瘤抑制因子与蛋白质精氨酸N-甲基转移酶3(PRMT3)相互作用,并在体外和体内抑制其甲基化底物的能力。
Oncogene. 2004 Oct 14;23(47):7761-71. doi: 10.1038/sj.onc.1208057.
7
Arginine methylation of NIP45 modulates cytokine gene expression in effector T lymphocytes.NIP45的精氨酸甲基化调节效应T淋巴细胞中的细胞因子基因表达。
Mol Cell. 2004 Aug 27;15(4):559-71. doi: 10.1016/j.molcel.2004.06.042.
8
Caspase activation: revisiting the induced proximity model.半胱天冬酶激活:重新审视诱导邻近模型。
Cell. 2004 Jun 25;117(7):855-8. doi: 10.1016/j.cell.2004.06.007.
9
Role of AIF in caspase-dependent and caspase-independent cell death.凋亡诱导因子在依赖半胱天冬酶和不依赖半胱天冬酶的细胞死亡中的作用。
Oncogene. 2004 Apr 12;23(16):2785-96. doi: 10.1038/sj.onc.1207517.
10
Influence of an altered methylation potential on mRNA methylation and gene expression in HepG2 cells.甲基化潜能改变对HepG2细胞中mRNA甲基化和基因表达的影响。
Exp Cell Res. 2004 Apr 1;294(2):325-34. doi: 10.1016/j.yexcr.2003.12.001.